Related Experiment Video
Updated: May 2, 2026

06:48
A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
1.4K
Single-cell transcriptomic analysis of Alzheimer's disease
Hansruedi Mathys1,2, Jose Davila-Velderrain3,4, Zhuyu Peng1,2
1Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nature
|May 3, 2019
Summary
This study analyzed brain cells from individuals with Alzheimer's disease (AD), revealing distinct cell subpopulations and early, cell-type specific changes. Myelination processes were significantly altered, highlighting their role in AD.
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- Alzheimer's disease (AD) is a complex neurodegenerative disorder with poorly understood molecular mechanisms.
- Existing research often lacks cell-type specific resolution for AD pathology.
Purpose of the Study:
- To investigate the molecular and cellular heterogeneity of Alzheimer's disease using single-nucleus transcriptomics.
- To identify cell types and pathways most affected by AD pathology across disease progression.
Main Methods:
- Analysis of 80,660 single-nucleus transcriptomes from the prefrontal cortex of 48 individuals with varying AD pathology.
- Identification and characterization of transcriptionally distinct cell subpopulations across six major brain cell types.
Main Results:
- Discovered cell-type specific subpopulations associated with AD, involving myelination, inflammation, and neuron survival regulators.
- Observed early, specific transcriptional changes in disease progression, with late-stage genes related to global stress response.
- Identified sex-specific transcriptional differences and overrepresentation of female cells in disease-associated subpopulations.
Conclusions:
- Myelination processes are recurrently perturbed across multiple cell types, suggesting a key role in Alzheimer's disease pathophysiology.
- The study provides a valuable single-cell transcriptomic resource for understanding the molecular basis of AD.
- Sex differences in cellular responses are critical for understanding AD pathogenesis.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35

